New siRNA Nanotherapy for Inflammatory Bowel Diseases, targeting Janus kinases

Project Information

NEW DEAL

Grant agreement ID: 720905

DOI 10.3030/720905

Project closed

EC signature date 9 November 2016

Start date 1 January 2017

End date 30 September 2021

Funded under

• INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies – Nanotechnologies

Total cost € 5 999 178,75

EU contribution € 5 999 178,75

Coordinated by

COMMISSARIAT A L ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES
France